文献速递神经肿瘤

成人胶质瘤患者的精神科共病、痛苦及心理社会服务使用情况——一项前瞻性研究

Psychiatric co-morbidity, distress, and use of psycho-social services in adult glioma patients-a prospective study.
PubMed 文献 · Acta Neurochir (Wien) · 2018-03-29

该前瞻性研究连续纳入37例成人胶质瘤患者,采用医院焦虑抑郁量表在入院时、出院前、3个月和6个月评估痛苦水平,并在出院前用DSM-IV结构式临床访谈确定精神障碍。结果显示各时间点痛苦升高比例分别为56%、59%、39%和40%,仅部分患者接受精神心理服务,未发现性别对精神科共病、痛苦或服务使用有影响。

要点

  • 37例胶质瘤患者中19%被诊断精神障碍,各时间点痛苦升高比例为56%、59%、39%和40%。
  • 住院期间痛苦升高者中14%接受精神肿瘤科医生访视,出院后43%就诊神经精神科医生、14%就诊心理治疗师。
  • 未发现性别对精神科共病、痛苦或服务使用有影响。

核心结论

  • 相当比例的胶质瘤患者在住院期间及之后报告痛苦升高,但仅一小部分患者接受精神心理卫生服务。

研究设计与样本

  • 前瞻性研究,连续纳入37例成人胶质瘤患者,在入院时(t1)、出院前(t2)、3个月(t3)和6个月(t4)使用医院焦虑抑郁量表评估痛苦水平。
  • 在t2使用DSM-IV结构式临床访谈确定精神障碍,通过医院信息系统确定院内精神肿瘤科照护,并在t4使用卫生保健使用问卷评估门诊治疗使用情况。
  • 比较男性和女性在痛苦升高百分比、精神科共病及照护使用方面的差异。

主要发现

  • 19%的患者被诊断患有精神障碍。
  • 痛苦升高的患者百分比在t1、t2、t3和t4分别为56%、59%、39%和40%。
  • 未存活至6个月的患者表现出更高水平的痛苦。
  • 在院内,痛苦升高者中有14%接受精神肿瘤科医生访视;在门诊,痛苦升高者中有43%就诊神经精神科医生,14%就诊心理治疗师。
  • 没有证据表明性别对精神科共病、痛苦或照护使用有影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Distress impacts the daily life of glioma patients. This study explored its course over time and the usage of psychosocial care. METHODS: A consecutive sample of glioma patients completed the Hospital Anxiety and Depression Scale to assess distress levels at admission to the hospital (t1), before discharge (t2), after 3 months (t3), and after 6 months (t4). They were interviewed with the Structured Clinical Interview for DSM-IV to ascertain psychiatric disorders at t2. Psycho-oncological care in the hospital was determined with the Hospital Information System, and the use of outpatient treatment was evaluated with the Health Care Usage Questionnaire at t4. We compared the percentages of elevated distress, psychiatric co-morbidity, and care usage between men and women. RESULTS: During the study period, 37 patients were enrolled. Nineteen percent of the patients were diagnosed with a psychiatric disorder. The percentages of patients with elevated distress were 56, 59, 39, and 40% at t1, t2, t3, and t4, respectively. Participants who did not survive the 6 months presented with higher levels of distress. In the hospital, 14% of those with elevated distress were visited by a psycho-oncologist. In the outpatient setting, 43% of those with elevated distress visited a neuro-psychiatrist, and 14% went to a psychotherapist. There was no evidence for an effect of gender on psychiatric co-morbidity, distress, or care use. CONCLUSIONS: A significant proportion of glioma patients report elevated distress during the hospital stay and thereafter. Only a fraction of them receive mental health care.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Singer S, Roick J, Danker H, et al. Psychiatric co-morbidity, distress, and use of psycho-social services in adult glioma patients-a prospective study. Acta Neurochir (Wien). 2018. PMID: 29594548. doi:10.1007/s00701-018-3527-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。